Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | University of Health Sciences | Turkey

Prof. Dr. Neslihan Üstündağ Okur is a distinguished scholar in pharmaceutical technology with a career dedicated to advancing innovative drug delivery systems. She earned her Bachelor of Pharmacy, Master’s degree, and PhD from Ege University, focusing her research on microemulsions, transdermal formulations, and ocular nano-carrier systems. Her academic journey has included roles as Research Assistant, Assistant Professor, Associate Professor, and currently Professor at the University of Health Sciences, Faculty of Pharmacy, where she also serves as Dean and Head of the Pharmaceutical Technology Department. She has held significant administrative positions at Istanbul Medipol University and has contributed extensively to the development of pharmaceutical formulations including microemulsions, solid lipid nanoparticles, in situ gels, dermal and ocular delivery systems, and sustained release technologies. Prof. Dr. Okur is actively engaged with professional organizations such as TÜFTAD, CRS, and ATINER. With a strong citation record and international recognition, she continues to shape pharmaceutical sciences globally.

Publication Profile

Google scholar

Educational Background

Prof. Dr. Neslihan Üstündağ Okur has pursued an impressive academic journey in pharmaceutical technology, building a strong foundation at Ege University. She completed her Bachelor of Pharmacy at the Faculty of Pharmacy, where she developed a deep interest in innovative drug delivery systems. Her academic path continued with a Master’s degree in Pharmaceutical Technology, where she focused on the in vitro and in vivo evaluation of transdermal microemulsion formulations containing naproxen, a study that highlighted her dedication to advancing therapeutic applications. She further strengthened her expertise by completing her doctoral research at the same institution, where her thesis explored the in vitro and in vivo evaluation of ocular nano-carrier systems containing antibiotics, contributing valuable insights into ocular drug delivery. This comprehensive academic background has laid the groundwork for her distinguished career, equipping her with advanced knowledge and innovative approaches in pharmaceutical sciences.

Professional Experience

Prof. Dr. Neslihan Üstündağ Okur has built an extensive career in pharmaceutical technology through progressive academic and administrative roles. She is currently serving as Professor at the University of Health Sciences, Faculty of Pharmacy, where she holds dual leadership positions as Dean of the Faculty of Pharmacy and Head of the Pharmaceutical Technology Department. Prior to this, she contributed as Associate Professor at the same institution, also leading the department with dedication. Her career includes valuable service at Istanbul Medipol University, where she held positions as Associate Professor and Vice Dean, and earlier as Assistant Professor and Head of the Pharmaceutical Technology Department. She began her academic journey at Ege University, serving first as a Research Assistant and later as Research Assistant with a doctoral focus, gaining deep expertise in drug delivery systems and pharmaceutical formulations. Throughout her career, she has demonstrated leadership, innovation, and a strong commitment to advancing pharmaceutical sciences.

Research Focus

Prof. Dr. Neslihan Üstündağ Okur’s research focus lies predominantly in the field of pharmaceutical technology, with particular emphasis on advanced drug delivery systems and innovative therapeutic formulations. Her work explores a wide range of drug carriers including polymeric systems, nano-structured lipid carriers, solid lipid nanoparticles, microemulsions, in situ gels, and composite films, targeting enhanced dermal, transdermal, and ocular drug delivery. She has made significant contributions to wound management through the development of polymeric carriers and novel dermal applications, as well as to ocular therapy with nanostructured platforms designed to improve bioavailability and treatment efficacy. Her studies further extend to anti-inflammatory and antifungal drug formulations, the use of stimuli-responsive nanoparticles, and nanotheranostic platforms for diagnostic and therapeutic purposes. By integrating in vitro and in vivo evaluations, she bridges experimental research with clinical applications, positioning her expertise at the intersection of pharmaceutical innovation, nanotechnology, and targeted drug delivery solutions.

Publication Top Notes

Recent trends on wound management: New therapeutic choices based on polymeric carriers
Year: 2020
Citations: 349

Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses
Year: 2016
Citations: 230

Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities
Year: 2021
Citations: 180

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations
Year: 2011
Citations: 149

Conclusion

Prof. Dr. Neslihan Üstündağ Okur is highly suitable for the Research for Best Researcher Award. Her innovative work in advanced drug delivery systems positions her as a leading figure whose contributions merit this recognition.

Alexandre Detappe | Nanomedicine Award | Young Scientist Award

Prof. Alexandre Detappe | Nanomedicine Award | Young Scientist Award

Prof. Alexandre Detappe, ICANS, France

Prof. Alexandre Detappe is a distinguished biophysicist and a leading figure in cancer research. Holding a PhD from the University of Lyon, France, he has contributed significantly to understanding and combating diseases like multiple myeloma and HER2+ breast cancer. Currently a Professor at Strasbourg Medical School, his research focuses on developing innovative drug delivery systems and small molecules to enhance immune responses against cancer. With extensive academic and institutional appointments, he co-founded several biotech companies, reflecting his commitment to translating research into practical solutions. Detappe’s multifaceted expertise and leadership in translational medicine make him a pivotal figure in advancing cancer therapeutics. 🧬🩺🔬

 

PUBLICATION PROFILE

Orcid

EDUCATION

Dr. Alexandre Detappe is a distinguished scholar in biophysics, with a rich educational background spanning renowned institutions in France. He earned his Bachelor’s degree in Physics and Science for Engineering from the University of Strasbourg in 2010. Subsequently, he pursued a Master’s degree in Medical Physics at the University of Grenoble, graduating in 2012. Dr. Detappe furthered his expertise with a Medical Physics residency at CEA Saclay in 2012-2013. His academic journey culminated in a PhD in Biophysics from the University of Lyon in 2017, followed by obtaining French authorization to supervise research from the University of Strasbourg in 2020. 🎓🔬

 

AWARDS

Dr. Alexandre Detappe’s groundbreaking contributions in biophysics and cancer research have garnered him numerous prestigious awards and fellowships. In 2021, he was honored with the Guy Ourisson Award by Cercle Gutenberg/University of Strasbourg, recognizing his outstanding achievements. His exceptional work also earned him the Brigitte Mérand Award from the Force Hémato Foundation in 2020 and the Brian D Novis Research Grant Award from the International Myeloma Foundation. Notably, his research excellence was acknowledged with the ASH Abstract Achievement Award in 2018 and the Marie Curie Award for the Best PhD in Radiation Oncology in 2016. Dr. Detappe’s accolades highlight his significant contributions to advancing medical science. 🏆🔬

 

RESEARCH FOCUS

Dr. Alexandre Detappe’s research spans various facets of cancer therapy and imaging, with a particular focus on leveraging nanotechnology for improved treatment outcomes. He explores innovative strategies such as nanoparticle-mediated drug delivery, image-guided radiation therapy, and molecular targeting. His work aims to enhance treatment efficacy while minimizing side effects, particularly in cancers like multiple myeloma and breast cancer. Through a multidisciplinary approach integrating biophysics, molecular biology, and nanomedicine, Dr. Detappe pioneers advancements in precision medicine, striving to make cancer therapies more effective and accessible. 🧬⚗️🔬

 

PUBLICATION TOP NOTES